April 09, 2018
Rose
Despite an intense lobbying push, drugmakers weren't able to convince lawmakers to let them off the hook for beneficiaries that fall into the doughtnut hole, raising questions about the industry's current clout. Meanwhile, a drug distributor has been accused of illegally pooling leftover cancer medications to sell to providers; Norvatis is buying gene-therapy company AveXis; a powerful pharmaceutical company dabbles in vineyards; and more.
from Kaiser Health News https://ift.tt/2qj3ku0
April 09, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Social, Environmental Factors Can Provide Missing Link To What’s Causing Health Problems For Patients- Move Over Marlboro Man: Big Tobacco Is Now Turning To Social Media Influencers To Make Smoking Look Cool
- Medicaid Expansion Clears Hurdle To Get On Nebraska Ballot But Legal Challenge Could Throw Wrench In Process
- Risks Of Taking An Aspirin A Day Don’t Outweigh The Benefits For People Who Haven’t Had Their First Heart Attack
- What Was Lost When Embryos Were Destroyed? Facilities’ ‘Catastrophic Failures’ Spark Emotionally Charged Debate
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment